Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Biochemical and Biophysical Research Communications|December 14, 2002
Implication of the exon region in the regulation of the human telomerase reverse transcriptase gene promoterStéphanie Renaud, Fred T Bosman, Jean Benhattar
Biochimica Et Biophysica Acta. General Subjects|March 18, 2023
Characterization of chitinases from the GH18 gene family in the myxomycete Physarum polycephalumStéphanie Renaud, Audrey Dussutour, Fayza Daboussi, et al.
Applied and Environmental Microbiology|November 6, 2004
Glutamine, glutamate, and alpha-glucosylglycerate are the major osmotic solutes accumulated by Erwinia chrysanthemi strain 3937Renan Goude, Stéphanie Renaud, Sylvie Bonnassie, et al.
Plos One|October 4, 2014
High expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cellsLoredana Alberti, Stéphanie Renaud, Lorena Losi, et al.
Nucleic Acids Research|December 6, 2005
CTCF binds the proximal exonic region of hTERT and inhibits its transcriptionStéphanie Renaud, Dmitri Loukinov, Fred T Bosman, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2015
Recent advances in cancer treatment by iron chelatorsVincent Corcé, Sébastien G Gouin, Stéphanie Renaud, et al.
Biochemical Pharmacology|June 14, 2015
Quilamine HQ1-44, an iron chelator vectorized toward tumor cells by the polyamine transport system, inhibits HCT116 tumor growth without adverse effectStéphanie Renaud, Vincent Corcé, Isabelle Cannie, et al.
Bioconjugate Chemistry|January 16, 2014
Synthesis and biological properties of Quilamines II, new iron chelators with antiproliferative activitiesVincent Corcé, Stéphanie Renaud, Isabelle Cannie, et al.
The Journal of Pathology|October 7, 2009
PAX5 activates the transcription of the human telomerase reverse transcriptase gene in B cellsStéphanie Bougel, Stéphanie Renaud, Richard Braunschweig, et al.
Nucleic Acids Research|October 27, 2007
Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factorsStéphanie Renaud, Elena M Pugacheva, M Dolores Delgado, et al.
Pageof 2